Integration and Expression of Retrovirus DNA

逆转录病毒DNA的整合和表达

基本信息

  • 批准号:
    6522715
  • 负责人:
  • 金额:
    $ 39.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-09-01 至 2006-08-31
  • 项目状态:
    已结题

项目摘要

Integration of viral into host cell DNA is a central and unique feature of retrovirus replication, and is directly responsible for many of the special characteristics of this important group of viruses, including their ability to cause cancer by activating and transducing oncogenes, their evolutionary persistence as endogenous viruses in the host germline, their very broad pathogenic spectrum, and their ability to serve as vectors for the gene therapist. Although the biochemical and structural aspects of the integration process are becoming quite well worked out, many important features remain unknown, including what defines an integration target, the relationship between chromatin and DNA structure and integration specificity, and the effect of the location of the integrated provirus on its subsequent expression. The overall goal of this project is to improve our understanding of key aspects of the role of integration in the virus-host interaction. Specifically, we will address the following questions: 1. Can we define an optimal target sequence (or structure) for integrase in vitro? What are the structural correlates of integrase targeting? How does the intracellular environment affect the use of certain sequences (or structures) as targets? 2. How does the structure, location, and activity of a region of cellular DNA affect its use as an integration target? In particular, we will test the hypothesis, based on our prior work, that integration has no strong regional preference, and that (contrary to prior ideas), increasing transcriptional activity of a gene does not enhance is use as an integration target, but rather reduces it, as a consequence of interference of bound transcription factors. 3. How does integration affect subsequent expression of the provirus. Why is integration apparently required for efficient expression? What is the role of the integration site in the level of transcription of the integrated provirus? In particular, what is the basis for "position effects" leading to clone-to-clone variation in expression of integrated proviruses?
病毒整合到宿主细胞DNA中是逆转录病毒复制的中心和独特特征,并且直接负责这一重要病毒组的许多特殊特征,包括它们通过激活和转导癌基因引起癌症的能力,它们作为宿主生殖系中的内源性病毒的进化持久性,它们非常广泛的致病谱,以及它们作为基因治疗师的载体的能力。 虽然整合过程的生化和结构方面已经得到很好的研究,但许多重要的特征仍然未知,包括什么定义了整合靶点,染色质和DNA结构与整合特异性之间的关系,以及整合前病毒的位置对其随后表达的影响。 本项目的总体目标是提高我们对整合在病毒-宿主相互作用中的作用的关键方面的理解。 具体而言,我们将解决以下问题:1.我们能否在体外确定整合酶的最佳靶序列(或结构)? 整合酶靶向的结构相关性是什么? 细胞内环境如何影响某些序列(或结构)作为靶标的使用?2.细胞DNA区域的结构、位置和活性如何影响其作为整合靶点的作用? 特别是,我们将测试的假设,根据我们以前的工作,整合没有强烈的区域偏好,并且(与以前的想法相反),增加基因的转录活性不会增强它作为整合靶点,而是减少它,作为干扰结合转录因子的结果。3.整合如何影响原病毒的后续表达。 为什么整合显然是高效表达所必需的? 整合位点在整合前病毒的转录水平中起什么作用? 特别是,什么是“位置效应”的基础上,导致克隆到克隆的综合前病毒表达的变化?

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN M COFFIN其他文献

JOHN M COFFIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN M COFFIN', 18)}}的其他基金

Retrovirus Evolution and Cancer
逆转录病毒进化与癌症
  • 批准号:
    10246396
  • 财政年份:
    2016
  • 资助金额:
    $ 39.63万
  • 项目类别:
Retrovirus Evolution and Cancer
逆转录病毒进化与癌症
  • 批准号:
    10006125
  • 财政年份:
    2016
  • 资助金额:
    $ 39.63万
  • 项目类别:
Retrovirus Evolution and Cancer
逆转录病毒进化与癌症
  • 批准号:
    10470889
  • 财政年份:
    2016
  • 资助金额:
    $ 39.63万
  • 项目类别:
Retrovirus Evolution and Cancer
逆转录病毒进化与癌症
  • 批准号:
    9201540
  • 财政年份:
    2016
  • 资助金额:
    $ 39.63万
  • 项目类别:
Developmental
发育性
  • 批准号:
    7676170
  • 财政年份:
    2008
  • 资助金额:
    $ 39.63万
  • 项目类别:
Developmental
发育性
  • 批准号:
    7278953
  • 财政年份:
    2007
  • 资助金额:
    $ 39.63万
  • 项目类别:
Retrovirus Evolution
逆转录病毒进化
  • 批准号:
    7780021
  • 财政年份:
    2001
  • 资助金额:
    $ 39.63万
  • 项目类别:
Retrovirus Evolution
逆转录病毒进化
  • 批准号:
    8239504
  • 财政年份:
    2001
  • 资助金额:
    $ 39.63万
  • 项目类别:
Retrovirus Evolution
逆转录病毒进化
  • 批准号:
    7033479
  • 财政年份:
    2001
  • 资助金额:
    $ 39.63万
  • 项目类别:
Integration and Expression of Retrovirus DNA
逆转录病毒DNA的整合和表达
  • 批准号:
    6616778
  • 财政年份:
    2001
  • 资助金额:
    $ 39.63万
  • 项目类别:

相似海外基金

Routes of Congenital Transmission of Avian Leukosis Virus
禽白血病病毒的先天性传播途径
  • 批准号:
    68B4836
  • 财政年份:
    1968
  • 资助金额:
    $ 39.63万
  • 项目类别:
Routes of Congenital Transmission of Avian Leukosis Virus
禽白血病病毒的先天性传播途径
  • 批准号:
    66B4836
  • 财政年份:
    1966
  • 资助金额:
    $ 39.63万
  • 项目类别:
Routes of Congenital Transmission of Avian Leukosis Virus
禽白血病病毒的先天性传播途径
  • 批准号:
    64B2129
  • 财政年份:
    1964
  • 资助金额:
    $ 39.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了